SA
Log In
ABEO
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
9 analysts·Limited coverage
67
Score
6 Buy (67%)3 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
667%
Hold
333%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
+189.4%
Consensus
$17.00
+189.4%
Bull
$17.00
+189.4%
12-Month Target Range9 analysts
$17.00$17.00$17.00
Current $5.87Consensus
Current Price
$5.87
Upside to Consensus
$11.13

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+132.05%
EPS—
FY2028
Rev+64.61%
EPS+742.59%
FY2029
Rev+21.13%
EPS+40.66%

Earnings Surprises

Recent Analyst Actions

Mar 17, 2026Stifel Nicolaus
Abeona Therapeutics (ABEO) PT Lowered to $17 at Stifel on Zevaskyn sales estimates
Target:$17.00
+257.1%from $4.76
May 16, 2025Stifel Nicolaus
Abeona Therapeutics price target lowered to $20 from $21 at Stifel
Target:$20.00
+227.9%from $6.10
Mar 5, 2025Oppenheimer
Abeona Therapeutics initiated with an Outperform at Oppenheimer
Target:$16.00
+204.2%from $5.26
Nov 14, 2022Leerink Partners
SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6
Target:$6.00
+44.6%from $4.15

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance